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Abstract
Objective: The adherence to a Mediterranean Dietary Pattern ensures an adequate
intake of B vitamins and w-3 fatty acids. A protective role on depression has been
suggested for both nutrients.
Design: Cross-sectional analysis from the SUN (Seguimiento Universidad de Navarra)
prospective cohort study. Data from 9670 participants (4211 men and 5459 women)
were analised. Logistic regression analyses were fitted to assess the association
between B-vitamins and w-3 fatty acids intake (quintiles) and the prevalence of
depression.
Results: Folate intake was inversely associated with depression prevalence among
men, especially smokers. Among women, B12 vitamin intake was inversely associated
with depression, especially among smokers and physically active women. No
significant associations were observed for w-3 fatty acids intake.
Conclusions: The adherence to a Mediterranean Dietary Pattern ensures an adequate
intake of fruits, nuts, vegetables, cereals, legumes or fish, important sources of
nutrients linked to depression prevention.
Depression and diet
Several investigations have established the relationship
between the foods the person eats and the manner the
person acts or feels. Diet has been associated not only with
mood fluctuations but also with several mental diseases
and behavioural problems like autism, attention-deficit/
hyperactivity disorder, schizophrenia, dementia, antisocial
behaviour or depression.
We are at a critic moment regarding our mental health.
Worldwide, 450 million people suffer from mental or
neurological disorders or from psychological problems
related to alcohol or drug abuse; some of these problems
represent the most important causes of disability world-
wide1. The 2003 WHO report estimated that depression is
the leading cause of morbidity among women and the
fourth cause among men around the world (it is likely the
proportion is higher in developed countries). Among
subjects aged between 15 and 59 years, the disease is the
second cause of morbility2.
Thus, it is essetial to study depression and its associated
factors, including diet. And, how the Mediterranean diet
affects depression?
Mediterranean diet and B vitamins
The Mediterranean diet is a dietary pattern characterised
by a high fruits, nuts, vegetables, legumes, cereals, olive
oil, and fish consumption, a low meat and dairy products
consumption and a moderate alcohol intake. Thus, the
adherence to this pattern ensures an adequate intake of
vitamins, specifically B vitamins such as B1, B2, B12 and B6
vitamins and folic acid.
The protective role of these nutrients, especially of B6,
B12 and folic acid on cardiovascular disease, Alzheimer or
depressive disorders has been hypothesised by different
epidemiological studies in the last years3,4.
To understand the mechanisms of B vitamins involved in
depression, it is important todescribe thehomocysteinecycle.
Homocysteine is an intermediate product produced
in the methionine metabolism. Vitamin B12 and B6
serve as cofactors for enzymes involved in the
conversion of homocysteine to methionine and cysteine,
respectively. Methylenetetrahydrofolate reductase cata-
lyses the conversion of 5, 10-methylenetetrahydrofolate to
5-methyltetrahydrofolate, which remethylates homocys-
teine to methionine.
Moreover, methionine is a precursor of S-adenosyl-
methionine, which acts in several methylation reactions,
including those involving neurotransmitters (monoamines
and catecholamines) and phospholipids of the central
nervous system. Therefore, a decreased intake of B
vitamins may result in an accumulation of homocysteine
and in a decreased synthesis of monoamines in brain,
likely contributing to mechanisms related with the origins
of depression.
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On the other hand, folate metabolism is involved in
the biopterin-dependent neurotransmitters synthesis.
Tetrahydrobiopterin is a cofactor essential for the
synthesis of biogenic amines whose precursors are
tyrosine and tryptophan. Thus, folate deficiency may
impair the synthesis of serotonin, dopamine or
norepinephrine.
In conclusion, a deficit of B12 or B6 vitamins or folate
would lead to an accumulation of homocysteine or its
metabolites such as homocysteinic and cysteine sulphinic
acid. These metabolites may inhibit the S-adenosylmethio-
nine methylation reactions. In addition, its metabolites
might also have an excitotoxic effect on the N-methyl-D-
aspartate glutamate receptors in the central nervous
system. (Fig. 1)
Consequently, there are several mechanisms underlying
the protective role of B vitamins on depression.
Numerous epidemiological studies have shown high
prevalence of B vitamins deficiency in subjects with
depression. Similarly, an association between high serum
homocysteine levels and a higher prevalence of depress-
ive symptoms has been reported in numerous cross-
sectional and case-control studies.
A study comprising 412 subjects and published in 2005
showed an association of high homocysteine and low
plasma folic acid levels with an increased severity of
depressive symptoms among men. Likewise, when the
authors analysed the association between folate levels and
depressive symptoms in the overall sample, men and
women, being in the lowest quartile of folic acid was
associated with increased depressive symptoms5.
Similar results, but only among women, were obtained
in the Sacramento Area Latino Study on Aging (SALSA)
study, based on a US Latinos sample6. The OR for high
depression symptoms in women in the lowest third of
plasma folate was 2.04.
Penninx et al. did not find a significant effect on
depression for plasma folate levels in a study based on 700
disabled, nondemented women aged 65. However, the
subjects with B12 deficiency were 2.05 times as likely to be
severely depressed as were nondeficient subjects7.
There are evidences regarding the association between
plasma folate and vitamin B12 levels and the prevalence of
depressive symptoms, but what happens with intake?
The Kuopio Heart Study, a cohort study consisted of
2600 Finnish middle-aged men, analysed the relationship
between folate intake and risk of depression during 13
years of follow-up8. Those subjects below the median of
energy-adjusted folate intake had a significant higher risk
of getting discharge diagnosis of depression (RR 3.04, 95%
CI: 1.58, 5.86) than those who had a folate intake above
the median. There was no effect for a high vitamin B12
intake.
Low blood levels of folate have been linked with a poor
response to antidepressant treatment. For that reason, a
number of clinical trials have analysed whether the
Fig. 1 Homocysteine cycle. Partially adapted from Bjelland et al.9
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co-administration of vitamin B12, methylfolate, folinic acid
or folic acid with the antidepressant treatment enhanced
its effect.
Alpert et al. assessed the efficacy of methylfolate as an
adjunctive treatment among adults with major depressive
disorder and inadequate response to selective serotonin
re-uptake inhibitors treatment. Sixteen participants com-
pleted this 8-week prospective open trial. The adminis-
tration of folinic acid improved the depression scores on
the HAM-D-17 scale and on the CGI-I scale10.
In this sense, a systematic review of clinical trials was
carried out in 2004. The trials analysed the effectiveness of
folate administration vs. placebo administration in the
treatment of depression. Hamilton depression rating scale
scores after the follow-up period were lower among
patients who received folate than among subjects who
received placebo. Coppen found that adding folate
reduced statistically Hamilton score by 2.65 points [95%
confidence interval (CI) 25.07 to 20.13]. Pooling the
results of the two trials that compared folate with placebo
in addition to other psychotropic medication, the
weighted mean difference in Hamilton score between
the groups at trial end point favoured treatment with folate
(difference ¼ 22.65; 95% CI 24.93 to 20.38)11.
Nevertheless, the results obtained regarding the
administration of cobalamin failed to assess a beneficial
effect of this vitamin. A clinical trial analysing the effect of
vitamin B12 did not find a significant depressive score
differences between the administration of this vitamin or
placebo after 3 months of follow-up12.
B6 vitamin has also been studied as an adjuvant in
depression treatment. A wide range of doses and follow-
up periods has been analysed. Studies addressing
premenstrual syndrome and hormone-related depression
in women revealed a consistent message about the value
of using vitamin B6 supplementation
13.
Mediterranean diet and v-3 fatty acids
Mediterranean diet is characterised by a moderate
consumption of fish, main source of v-3 fatty acids.
v-3 fatty acids are long-chain polyunsaturated fatty
acids (PUFA) that cannot be synthesised in the human
body and therefore they have to be incorporated from
diet. The most important v-3 fatty acids are the a-linolenic
acid (ALA), the eicosapentaenoic acid (EPA) and the
docosahexaenoic acid (DHA). Vegetables are rich sources
of ALA. This fatty acid can be metabolised into EPA and
DHA. Similarly, EPA and DHA are provided by fish sources
such as mackerel, herring, anchovy or salmon.
There are several mechanisms of action of v-3 fatty
acids in depression. Depression is associated with
neuronal atrophy. Antidepressant medication can lead to
an increment in nerve growth factors such as brain-
derived neurotrophic factor which improves neurotrans-
mission and synaptic plasticity. A number of investigations
suggest that depression is associated with excessive
production of proinflammatory cytokines. Proinflamma-
tory cytokines and prostaglandin E2 may inhibit brain-
derived neurotrophic factor expression. v-3 fatty acids
have been suggested as inhibitors of proinflammatory
mediators synthesis such as cytokines, especially tumour
necrosis factor a (TNF-a) and interleukin 1b (IL-1b),
increasing, as a result, brain-derived neurotrophic factor.
Moreover, proinflammatory cytokines interfere in neuro-
transmitters metabolism and alter neurotransmitters
mRNA. In the same way, cytokines may decrease
serotonin precursors such as tryptophan and activate the
hypothalamic pituitary adrenal axis causing resistance to
glucocorticoid hormones. Finally, a change in the fatty
acids composition of central nervous system membranes
may alter their functions by changing fluidity and
biophysical properties as well as neurotransmitters
availability.
The first epidemiological evidence regarding the
protective role of v-3 fatty acids intake on depression
comes from ecological studies. Hibbeln published the
results of an ecological study, where an increment in fish
consumption was correlated with a decreased annual
prevalence of depression worldwide14. Hibbeln found
similar negative correlation between total seafood
consumption and the prevalence of post-partum
depression15.
Several case-control studies have also analysed the
association between v-3 fatty acid levels and depressive
disorders. A nested case-control study was conducted
within the Rotterdam cohort study. This population-based
study showed that fatty acid composition of plasma
phospholipids was associated with depressive disorders16.
Subjects with depressive disorder had a significant lower
percentage of v-3 fatty acids in plasma phospholipids than
did the group without depressive symptoms.
Recently, other case-control study found similar results
in patients recovering from acute coronary syndromes.
Major depression was associated with significantly lower
plasma levels of v-3 fatty acids17.
However, only one cohort study has assessed the
association between v-3 fatty acids intake and the risk of
depression. The study failed to find a statistically
significant association between fish consumption or v-3
fatty acids intake and the risk of depression among Finnish
men after 9 years of follow-up. Depression was defined as
a self-reported depressed mood and as the presence of a
hospital treatment due to depression. None of the
definitions of depression were related to the amount of
fish or v-3 fatty acids intake18.
The results obtained from clinical trials are contra-
dictory. Some of the trials fail to find a beneficial effect of
the co-administration of v-3 fatty acid supplements on
depression treatment. On the other hand, several trials
have suggested a positive role for these nutrients. In a
clinical trial published in 2005 where the patients were
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randomly assigned to receive either olive oil or DHA-
enriched fish oil, there were statistically significant
differences in plasma v-3 fatty acids levels between the
two groups. However, both treatments achieved signifi-
cant decreases in Hamilton scale scores after 2 weeks of
intervention19.
Mediterranean diet and the SUN Project
A growing body of research indicates a protective
effect of different components of the Mediterranean
diet on depression, like B vitamins or v-3 fatty acids. In
this context, it is necessary to introduce the SUN
Project.
The SUN Project (Seguimiento Universidad de Navarra-
Follow-up University of Navarra) is a prospective cohort
study designed to establish the association between
several dietary habits or lifestyle-related characteristics
and the occurrence of several diseases and chronic
conditions, including depression20. The recruitment of
participants started in December 1999 and it is perma-
nently ongoing as this is a dynamic cohort study.
Information is collected using self-administered question-
naires sent by postal mail every two years.
Study subjects
The baseline questionnaires of 11 623 participants were
coded, processed and ready for statistical analysis. Those
participants who reported extremely low or high values
for total energy intake (less than 600 and 400Kcal day21 in
men and women, respectively, or more than 4200 and
3500 Kcal day21 in men and women, respectively)
(n ¼ 1381), and subjects with a diagnosis of depression
at an age prior to the age reported in the baseline
questionnaire (n ¼ 572) were excluded. Finally, data from
9670 participants (4211 men and 5459 women) remained
available for the analysis.
Exposure assessment
The dietary exposure was ascertained through a semi-
quantitative food frequency questionnaire (136 food
items) previously validated in Spain21. For the present
analyses, we considered B12, B6, folic acid and v-3 fatty
acids intake as exposure factors.
B vitamins and v-3 fatty acids intakes were adjusted
for total energy intake using the residuals method.
Then, the continuous variables were categorised in
quintiles considering the first quintile as the reference
category.
Outcome assessment
Depression was assessed though a question included in
the baseline questionnaire. Participants responded to the
following question: have you ever been diagnosed of
depression by a health professional? The baseline
questionnaire collected the use of regular antidepressant
medication as well.
Recent depression was defined as the positive answer to
either the question regarding physician-diagnosed
depression or participant reporting of the use of
antidepressant medication in baseline questionnaire.
Covariables assessment
The baseline assessment also included other questions
(totally 46 items for men and 54 items for women) . Socio-
demographic (e.g. gender, age, marital status and employ-
ment status), anthropometric (e.g. weight and height),
lifestyle and health-related habits (e.g. smoking status,
caffeine and alcohol intake and physical activity during
leisure time), psychological characteristics (e.g. personality
traits) and medical history variables (e.g. prevalence of
chronic diseases and medication use) were also collected.
Results
We found no statistically significant associations between B
vitamins intake and the prevalence of depression among
men, although some point estimates for odds ratios (ORs)
suggested an inverse association with folate intake. The
multivariate-adjusted ORs (95% confidence intervals) for
depression for successive quintiles of energy-adjusted
folate intake were 1 (reference), 0.81 (0.51–1.28), 0.77
(0.48–1.25), 0.72 (0.43–1.20) and 1.01 (0.57–1.79). When
the analyses were carried out according to several
characteristics, we found an inverse association between
energy-adjusted folate intake and the prevalence of
depression among men who were current smokers.
The ORs for depression in this group of men were 0.31
(0.12–0.82), 0.25 (0.08–0.75) and 0.52 (0.17–1.57) for the
third to fifth quintiles, respectively, as compared to the
reference quintile (Fig. 2).
We found a significant inverse association between
energy-adjusted vitamin B12 intake and prevalence of
depression among women. ORs (95% CI) for successive
quintiles of intake were 0.65, (0.46–0.91), 0.58 (0.41–
0.84), 0.56 (0.38–0.82) and 0.68 (0.45–1.04), respectively.
There were not statistically significant associations
Fig. 2 Association between folate intake and depression preva-
lence in males who were current smokers in the SUN study. Q1,
first quintile; Q2–Q5, second–fifth quintile
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between folic acid or vitamin B6 intake and the prevalence
of depression in females.
When the analyses were restricted to women who
reported moderate physical activity level or to women
who were current smokers, depression prevalence could
be around 50% lower among whose vitamin B12 intake
was in the Q2–Q5 than among women in the reference
category of intake (Fig. 3).
There were no statistically significant associations
between v-3 fatty acids intake and depression. However,
there was a protective trend for women.
Conclusions
. There were no statistically significant associations
between B6 vitamin intake and depression prevalence.
. Folate intake was inversely associated with depression
prevalence among men, especially among smokers.
. B12 vitamin intake was inversely associated with
depression among women, especially among smokers
and physically active women.
. v-3 fatty acids intake seems to be protective only among
women.
. It is necessary to continue studying these associations in
prospective analyses.
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